- Home
- BGY vs SIGA Comparison
BGY vs SIGA Comparison
Compare BGY & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGY
- SIGA
- Stock Information
- Founded
- BGY 2007
- SIGA 1995
- Country
- BGY United States
- SIGA United States
- Employees
- BGY N/A
- SIGA N/A
- Industry
- BGY Trusts Except Educational Religious and Charitable
- SIGA Biotechnology: Pharmaceutical Preparations
- Sector
- BGY Finance
- SIGA Health Care
- Exchange
- BGY Nasdaq
- SIGA Nasdaq
- Market Cap
- BGY 529.9M
- SIGA 443.4M
- IPO Year
- BGY N/A
- SIGA 1997
- Fundamental
- Price
- BGY $5.49
- SIGA $6.32
- Analyst Decision
- BGY
- SIGA
- Analyst Count
- BGY 0
- SIGA 0
- Target Price
- BGY N/A
- SIGA N/A
- AVG Volume (30 Days)
- BGY 208.4K
- SIGA 422.2K
- Earning Date
- BGY 01-01-0001
- SIGA 03-11-2025
- Dividend Yield
- BGY 7.41%
- SIGA 9.53%
- EPS Growth
- BGY N/A
- SIGA N/A
- EPS
- BGY N/A
- SIGA 1.20
- Revenue
- BGY N/A
- SIGA $173,731,386.00
- Revenue This Year
- BGY N/A
- SIGA $16.79
- Revenue Next Year
- BGY N/A
- SIGA $15.08
- P/E Ratio
- BGY N/A
- SIGA $5.30
- Revenue Growth
- BGY N/A
- SIGA 399.31
- 52 Week Low
- BGY $4.68
- SIGA $4.26
- 52 Week High
- BGY $5.66
- SIGA $12.83
- Technical
- Relative Strength Index (RSI)
- BGY 57.16
- SIGA 51.04
- Support Level
- BGY $5.20
- SIGA $6.16
- Resistance Level
- BGY $5.45
- SIGA $6.58
- Average True Range (ATR)
- BGY 0.06
- SIGA 0.26
- MACD
- BGY 0.02
- SIGA 0.04
- Stochastic Oscillator
- BGY 98.28
- SIGA 68.67
About BGY Blackrock Enhanced International Dividend Trust
Blackrock Enhanced International Dividend Trust has an investment objective to provide current income and current gains, with a secondary objective of long-term capital appreciation. The Trust seeks to achieve its objectives by investing in equity securities of companies engaged in the energy and natural resources business and equity derivatives with exposure to the energy and natural resources industry.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.